Logo Image
|Articles|July 31, 2020

In the Lab eNewsletter

  • Pharmaceutical Technology's In the Lab eNewsletter 08-05-2020
  • Volume 15
  • Issue 8

Primera Technology Introduces Signature Slide and Cassette Printers

The printers can print text, graphics, logos, and 2D bar codes directly onto slides and cassette.

Primera Technology introduced its Signature Slide and Cassette Printers with integrated PTLab software for increasing lab efficiency and reducing the risk of specimen misidentification.

According to a July 13, 2020 press release, the printers can print text, graphics, logos, and 2D bar codes directly onto slides and cassette. The devices also include:

  • On-demand, black or color printing
  • Small footprints
  • Reduced inventories and purchasing activity
  • Thermal-transfer printing at high-resolution, 300 dpi
  • On-demand or batch mode printing

Source: Primera Technology

Articles in this issue

about 6 years ago

Using Analytical Assays to Ensure Biosimilar Quality

about 6 years ago

A Novel Method for Host Cell Protein Analysis

about 6 years ago

MilliporeSigma Invests $20 Million in New Switzerland Laboratory

about 6 years ago

MOBILIon’s SLIM Technology Enhances R&D Analytics

about 6 years ago

Polyplus-transfection Launches Residual Test for Transfection Reagents

about 6 years ago

Rigenerand Develops 3D Bioreactor for Extracellular Vesicle Exosomes Production

about 6 years ago

Intravacc and Leiden University Develop Possible Replacement for Animal Testing in Vaccines

about 6 years ago

LabVantage Adds an SDMS to the 8.5 Edition of its LIMS Platform

Related to this article

View more
Complying with International Pharmacopoeias
Complying with International Pharmacopoeias
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
Read more
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Read more
Trophy and confetti on light background, top view with space for text. Victory concept | Image Credit: ©New Africa -stock.adobe.com
Winners of the 2026 CPHI Pharma Awards Announced
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Read more